We are an EN ISO 13485 certified EU-located company developing and producing CE IVD real-time PCR kits.
Our in vitro diagnostics fall into five categories: clinical genetics, hematology, pharmacogenetics, oncology and microbiology.
Our typical partners are end-users of the RT-PCR kits (mostly in CZ and SK), business partners and distributors. We are looking for business partners and/or distributors worldwide who can fit the portfolio of our products, either the whole or a part of it, to their sales strategy (see here).
gb HEMO FXIII (V34L) The CE IVD real-time PCR kit is intended for detection of mutation V34L in fibrin stabilizing factor XIII in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).
gb GENETIC Gilbert The CE IVD real-time PCR kit is intended for detection of polymorphism TA (allele 7TA) in gene UGT1A1 in human genomic DNA. Detection is based on polymerase chain reaction (PCR) with analysis of melting curves using fluorescently labelled probe.
gb GENETIC A1AT The CE IVD real-time PCR kit is intended for detection of mutations PI*S and PI*Z in the alpha 1 antitrypsin gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).
gb GENETIC APOE The CE IVD real-time PCR kit is intended for detection of mutations rs429358 and rs7412 in the gene for APOE in human genomic DNA. It enables determination of e2 (cys112, cys158), e3 (cys112, arg158) and e4 (arg112, arg158) genotypes. Examination process is based on a principle of real-time PCR with the use of fluorescently labelled probes (allelic discrimination).
gb PHARM DPYD*2A The CE IVD real-time PCR kit is intended for detection of mutation DPYD*2A (IVS14+1G>A) in gene for dihydropyrimidine dehydrogenase in human genomic DNA by real-time PCR method (allelic discrimination).
gb PHARM CYP2C19 The CE IVD real-time PCR kit is intended for detection of CYP2C19*2, CYP2C19*3 and CYP2C19*17 gene mutation. The detection principle is based on a real-time polymerase chain reaction (qPCR) using fluorescent labeled probes (allelic discrimination).
gb PHARM Warfarin The CE IVD real-time PCR kit is intended for detection of mutation CYP2C9*2, CYP2C9*3 and VKORC1 G1639A in human genomic DNA by real-time PCR method (allelic discrimination).
gb ONCO CLL The CE IVD real-time PCR kit is intended for prognosis assessment in CLL patients by analysis of cDNA (reverse transcribed RNA) samples of human B lymphocytes obtained from peripheral blood. The kit is based on reverse transcription together with quantitative real-time polymerase chain reaction (qRT-PCR) using fluorescently labelled probes.
gb ONCO JAK2 (V617F) The real-time PCR kit is used for detection and quantification of somatic mutation V617F JAK2 gene in human genomic DNA. The detection principle is based on real-time PCR using fluorescently labeled probes and allele specific primers.
Your request has been sent.
Your cycler has not been included in the list?
Send us the type of your cycler and we will find a solution for you.
Your request has been sent.
Thank you for your inquiry
Thank you for your inquiry
Your registration has been sent.
Thank you for your inquiry
Price will be calculated based on your exact location within 2 working days.
ENG 
CZE